Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch® 3-dimensional genomic regulatory immuno-genetic profiling
Ewan Hunter(Unknown), Dmitri Pchejetski(University of East Anglia), Alexandre Akoulitchev, Ann Dring, Ryan Powell, Caroline C. Kingdon(London School of Hygiene & Tropical Medicine), Abel Gebregzabhar, Dominik Vugrinec, Carol Wilson(Royal Cornwall Hospital Trust), J. Ludovic Croxford, Heba Alshaker(University of East Anglia), Cicely Weston, Sarah Dowrick(Royal Cornwall Hospital Trust), Oliver Bundock, Jayne Green
Cited by 14
Related Papers
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203
Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis
|Circulation Research|2006|197
The emerging role of FTY720 (Fingolimod) in cancer treatment
|Oncotarget|2016|174
Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting shingosine kinase-1
|Leukemia|2005|171
Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1
|European Heart Journal|2011|163